Fundraising Fox
Erisyon
Founded 2018 · 7 employees on LinkedIn · 3 known investors
Find your way into Erisyon
Sign up to find every way you can get introduced to Erisyon
- Your email: who you already know at Erisyon, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Erisyon team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Erisyon is a biotechnology company that develops technology to advance scientific and health discoveries, building on research from the University of Texas at Austin's Center for Systems and Synthetic Biology. It was founded in 2018 by a group of technologists and entrepreneurs.
Investors · 3
How we know: Catalio Capital Management, LP's portfolio page · Not right? Tell us
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements- Undisclosed amountseed capitalNov 2020
Research Bridge Partners
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through Erisyon went on to found or lead other companies.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $216.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $247.9K |
| National Science Foundation | Phase ISTTR | 2020 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Erisyon do?
- Erisyon is a biotechnology company that develops technology to advance scientific and health discoveries, building on research from the University of Texas at Austin's Center for Systems and Synthetic Biology. It was founded in 2018 by a group of technologists and entrepreneurs.
- Who are Erisyon's investors?
- Erisyon's investors include Catalio Capital Management, LP, Foothill Ventures.